When this stock will go back up is anyone’s guess.
From the website - It looks like the patent attorneys have been busy:
Avian Flu
US-SN 60/921,581 "Novel Sequence and Nucleic Acid Based Vaccine Against Avian Flu" 4/3/07 PENDING USA
Anti-Microbials
US-SN 60/994,042 "Novel Antibacterial Aptamers" 9/17/2007 PENDING USA
US-SN 11/664,052 "Single-Stranded Antimicrobial Oligonucleotides and Uses Thereof" 3/28/07 PENDING USA
US-SN 10/574,254 "Nucleotides for Prevention and Treatment of Bacterial and Fungal Pathologies" 3/30/06 PENDING USA
Single Stranded-DNA Expression Vector
US-SN 11/586,797 "Production of ssDNA In Vivo" 10/26/06 PENDING USA
I guess this is why we need the lab:
synDNA™
In addition to use of synDNA™ in CytoGenix's products, we have begun marketing it to other companies. Our present
capabilities are production of research grade material. We have identified outside sources that can produce "certified good manufacturing practice" (cGMP) material. This is the standard for clinical grade material. The Company is developing relationships with these sources to utilize their facilities if the need for cGMP material is required before our own production facility is completed and certified.
